Company Overview and News

2
Growing Cyber Crime Presents New Opportunity for Insurers

2018-09-21 zacks
Cyber insurance has gained increased popularity in recent years due to the rise in instances of cyber crime that calls for insurance against the calamities arising thereafter.
AVF AIG CB 8685

2
Insurers brace for another round of catastrophe losses from Hurricane Florence

2018-09-12 reuters
Sept 12 (Reuters) - U.S. insurers are bracing for what could be $20 billion in losses as Hurricane Florence barrels toward the Carolinas and Virginia, bringing punishing rains and potentially deadly flooding.
GJT TRV AVF AIG ZURVY ALL CB 8685 ZFSVF

6
Many Stocks Riding the Waves and Pressure of Hurricane Florence and Other Storms

2018-09-11 247wallst
Hurricane Florence is expected to hit the Carolinas as a major hurricane on Thursday and was already a category 4 hurricane on Tuesday. Evacuations, home repairs, and homes having to be entirely replaced can certainly create some serious issues for far more than just the simple damage and inconveniences. There is a serious impact on companies and local economies that also comes into play.
LOW HD BMCH PGR BLD HRI BGG STCK GNRC CB GJT JELD TRV OC CAR ALL URI HTZ

3
Hike in Commercial Insurance Rates is Good for These Stocks

2018-09-11 zacks
Leading global advisory, broking and solutions company Willis Towers Watson’ Commercial Lines Insurance Pricing Survey has revealed that Commercial insurance prices in the United States increased by nearly 3% year over year, during the second quarter of 2018. The survey found that price changes of this magnitude have not been reported in almost four years. This marked the third consecutive quarter of rate hike.
GJT TRV BRK.A ALL CB

2
Insurers Bracing for Hurricane Florence, More Storm Threats Coming

2018-09-10 247wallst
Hurricane Florence is expected to hit the Carolinas as a major hurricane on Thursday evening, and it coincides with what is generally projected to be the peak-week of the 2018 hurricane season. The 11:00 a.m. update from the National Hurricane Center showed that the hurricane eye is moving toward the west near 13 mph and will begin to move west-northwestward with an increase in forward speed expected during the next couple of days.
GJT TRV RE FNHC HRTG UVE ALL CB HCJ HCI UIHC HCIIP

 
Swiss Re: Strong Results, Possible Spin-Off

2018-09-04 seekingalpha
Swiss Re Group reported year-over-year growth in its latest results, with only net income showing a decline.
SSREY CB SSREF

3
Employers Holdings A Well-Run Play On Small Business Growth Through Workers Comp

2018-08-30 seekingalpha
Employers Holdings has established a good underwriting track record for workers' comp for small businesses, but rate headwinds are significant.
EIG BRK.A CB

11
Hartford Defies The Market And Announces A $2.1 Billion Deal For Navigators

2018-08-23 seekingalpha
Despite the fact that many investors wanted a large buyback, Hartford announced the $2.1 billion acquisition of The Navigators Group, a specialty-focused P&C insurer with a sizable marine insurance business.
NAVG LYG CB

 
Chubb Ltd 2018 Q2 - Results - Earnings Call Slides

2018-08-20 seekingalpha
The following slide deck was published by Chubb Ltd in conjunction with their 2018 Q2 earnings call.
CB

21
Top Analyst Upgrades and Downgrades: ADS, Blackstone, Cognizant, HCA, Paychex, Salesforce, Wynn, Yext, Zoetis and More

2018-08-14 247wallst - 1
Stocks were indicated to have a higher open on Tuesday after a Turkey-related sell-off on Monday. Earnings season is now about 85% over, and it has been quite strong with over 70% of the companies exceeding expectations. The market volatility in 2018 has created less rewarding trades by buying the dips, which had been so reliable in prior years. Many investors also are trying to decide how they want their investments positioned ahead of the midterm elections and with international trade concerns.
WFCNP DB HCA MS CB WFC CG DY ZTS BX TRI ADS

5
2 Funds to Gain From Trump???s New Health Insurance Rule

2018-08-09 zacks
The Trump administration recently released the final rule pertaining to short-term and limited-duration insurance coverages. The new order provides cheaper and effective short-term health plans to individuals and businesses that find policies under Obamacare unaffordable.
PRU GD AVF PFK MET FSPCX AIG MET PRH CB 8685 PJH

3
Insurance ETFs Looking Good Post Q2 Earnings

2018-08-08 zacks
The insurance industry has performed well this reporting cycle with robust earnings from leading players. Prominent players such as MetLife (MET - Free Report) , Chubb Corp (CB - Free Report) and Allstate (ALL - Free Report) surpassed earnings and revenue estimates. While American International (AIG - Free Report) and Travelers (TRV - Free Report) missed earnings estimates, Aflac (AFL - Free Report) lagged revenue estimates.
IAK PRU ALL AFL KIE PRH PFK MET CB PRU PJH

7
Q2 Scorecard & Research Reports for Gilead, American Tower & Others

2018-08-06 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Gilead (GILD), American Tower (AMT) and Chubb (CB). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
BRK.A NOC CBG AMT XOM UTX HUM CB AET CBRE

 
New York's Cuomo rejects NRA claim that 'blacklisting' jeopardizes mission

2018-08-04 reuters
NEW YORK (Reuters) - New York Governor Andrew Cuomo on Friday rejected a claim by the National Rifle Association that his efforts to get banks and insurers to stop doing business with the group threatened its ability to advocate for gun rights.
CB

50
Financials And Real Estate Dashboard - Update

2018-08-03 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages.
BAC BAC JPM CINF CB AJG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CB / Chubb Ltd on message board site Silicon Investor.

Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more. CBD oil CBD oil CBD oil
CCB vs ZEN truth board CCB vs ZEN truth board CCB vs ZEN truth board Canada Carbon CCB-V Canada Carbon CCB-V Canada Carbon CCB-V
ZEN vs CCB ZEN vs CCB ZEN vs CCB CB Richard Ellis Group, Inc. CB Richard Ellis Group, Inc. CB Richard Ellis Group, Inc.
CBIS.OB Cannabis Science CBIS.OB Cannabis Science CBIS.OB Cannabis Science CCB Free Speech Board CCB Free Speech Board CCB Free Speech Board
Northstar Electronic: NEIK-OTCBB Northstar Electronic: NEIK-OTCBB Northstar Electronic: NEIK-OTCBB CRAiLAR Technologies Inc. (OTCBB: CRLRF TSX: CL) CRAiLAR Technologies Inc. (OTCBB: CRLRF TSX: CL) CRAiLAR Technologies Inc. (OTCBB: CRLRF TSX: CL)
CUSIP: H1467J104